ACRIN-FMISO-BRAIN

DOI: 10.7937/K9/TCIA.2018.vohlekok | Image Collection

The objective of the ACRIN 6684 multi-center clinical trial was to determine the association of baseline FMISO PET uptake (maximal tumor to blood ratio, hypoxic volume) and MRI parameters (Ktrans, CBV) with overall survival, time to disease progression, and 6-month progression free survival in participants with newly diagnosed glioblastoma multiforme (GBM).ย The trial also collected standard brain...

EA1141

DOI: 10.7937/2BAS-HR33 | Image Collection

This collection contains data from the Eastern Cooperative Oncology Group (ECOG) Clinical Trialย NCT02933489, โ€œAbbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts". Principal Investigator: Christopher Comstock.ย ย It was sponsored by NCI and performed by the Eastern Cooperative Oncology Group under study...

NSCLC-CETUXIMAB

DOI: 10.7937/TCIA.2018.jze75u7v | Image Collection

This collection contains data from the National Cancer Insitute Clinical Trial NCT00533949, "High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery."ย  It was sponsored by NCI's Radiation Therapy Oncology Group...

LUNG-FUSED-CT-PATHOLOGY

DOI: 10.7937/k9/tcia.2018.smt36lpn | Image Collection

This is the first attempt of mapping the extent of Invasive Adenocarcinoma onto in vivo lung CT. The mappings constitute ground truth of disease and may be used to further investigate the imaging signatures of Invasive Adenocarcinoma in ground glass pulmonary nodules. Patient with small ground glass nodules with >2 histology slices per nodule were included. Patients with solid large nodules (>40mm), with <3...